Skip to main content
Year archive

IMAGION BIOSYSTEMS LIMITED — 2019 filings

All 65 regulatory filings released by IMAGION BIOSYSTEMS LIMITED (IBX) in 2019, sourced directly from the official regulator.

65 Filings
2019 Period
2019 filings (65)
Filing Released Lang
Response to ASX price query 5 pages 660.9KB
Regulatory Filings
2019-12-30 English
Response to ASX App 3Y Query 3 pages 547.5KB
Regulatory Filings
2019-12-11 English
Appendix 3B 13 pages 1.2MB
Regulatory Filings
2019-12-09 English
Cleansing Notice 1 page 900.1KB
Regulatory Filings
2019-12-09 English
Change of Director's Interest Notice - David LUDVIGSON 2 pages 172.4KB
Regulatory Filings
2019-12-08 English
Change of Director's Interest Notice- Mark VAN ASTEN 2 pages 27.0KB
Regulatory Filings
2019-12-08 English
Change of Director's Interest Notice - Robert PROULX 2 pages 171.5KB
Regulatory Filings
2019-12-08 English
Change in substantial holding 2 pages 147.2KB
Regulatory Filings
2019-12-01 English
Ceasing to be a substantial holder 1 page 71.2KB
Regulatory Filings
2019-11-28 English
Imagion Biosystems receives order to supply nanoparticles 1
Regulatory Filings
2019-11-26 English
Appendix 3B 12 pages 450.2KB
Regulatory Filings
2019-11-25 English
Completion of Renounceable Rights Issue 1 page 57.9
Regulatory Filings
2019-11-21 English
Imagion Biosystems' patent issued in India 1 page 1
Regulatory Filings
2019-11-12 English
Supplementary Prospectus 3 pages 157.7KB
Regulatory Filings
2019-11-07 English
Offer Update and Appendix 3B 10 pages 318.8KB
Regulatory Filings
2019-11-07 English
Appendix 4C - quarterly 7 pages 319.6KB
Regulatory Filings
2019-10-30 English
Rights Commence Trading 1 page 127.5KB
Regulatory Filings
2019-10-30 English
Pro-Rata Renounceable Rights Issue - Amended Timetable 2 pages 257.0KB
Regulatory Filings
2019-10-28 English
Pro-Rata Renounceable Rights Issue - Indicative Close Date 1
Regulatory Filings
2019-10-28 English
Renounceable Rights Issue - Eligible Shareholders 4 pages 353.3KB
Regulatory Filings
2019-10-28 English
Renounceable Rights Issue - Ineligible Shareholders 1
Regulatory Filings
2019-10-28 English
Investor Presentation 20 pages 9.3MB
Regulatory Filings
2019-10-27 English
Pro-Rata Renounceable Rights Issue 4 pages 677.2KB
Regulatory Filings
2019-10-27 English
Renounceable Rights Issue Prospectus 42 pages 358.1KB
Regulatory Filings
2019-10-27 English
Appendix 3B - Renounceable Rights Issue 8 pages 208.3KB
Regulatory Filings
2019-10-27 English
Imagion Biosystems Nanoparticle Manufacturing Update 2 pages 42.4KB
Regulatory Filings
2019-10-24 English
Appendix 3B 11 pages 383.8KB
Regulatory Filings
2019-10-21 English
IBX Establishes Scientific Advisory Board 2 pages 134.7KB
Regulatory Filings
2019-10-13 English
Appendix 3B 11 pages 343.0KB
Regulatory Filings
2019-10-03 English
Imagion Biosystems Investor Update 2 pages 171.2KB
Regulatory Filings
2019-10-01 English
Appendix 3B 11 pages 371.6KB
Regulatory Filings
2019-09-29 English
Cleansing Notice 1 page 92.9KB
Regulatory Filings
2019-09-29 English
MagSense Utility as a Potential MRI Contrast Agent 2 pages 61.6KB
Regulatory Filings
2019-09-08 English
Investor Presentation 17 pages 4.8MB
Regulatory Filings
2019-09-08 English
Appendix 4D and Half Year Report 19 pages 659.4KB
Regulatory Filings
2019-08-29 English
Imagion Biosystem's Newsletter 6 pages 343.0KB
Regulatory Filings
2019-08-22 English
IBX Regulatory Communications Update 1 page 122.3KB
Regulatory Filings
2019-08-05 English
Appendix 4C - quarterly 7 pages 1.1MB
Regulatory Filings
2019-07-29 English
Change in substantial holding 2 pages 96.2KB
Regulatory Filings
2019-07-25 English
Imagion Biosystems receives A$2 million in R&D tax incentive 1
Regulatory Filings
2019-07-24 English
Change in substantial holding 2 pages 147.2KB
Regulatory Filings
2019-07-24 English
FDA Breakthrough Device Designation 1 page 63.1KB
Regulatory Filings
2019-07-17 English
Final Director's Interest Notice 1 page 146.6KB
Regulatory Filings
2019-06-27 English
Appendix 3Y x 5 10 pages 295.4KB
Regulatory Filings
2019-06-26 English
Director Resignation - Dr. John Hazle 1 page 63.0KB
Regulatory Filings
2019-06-26 English
Ceasing to be a substantial holder 2 pages 138.0KB
Regulatory Filings
2019-06-24 English
Appendix 3B 11 pages 301.0KB
Regulatory Filings
2019-06-23 English
Release of Securities Subject to Escrow 1 page 70.8
Regulatory Filings
2019-06-06 English
Chairman's Address to Shareholders at Annual General Meeting 2 pages 83.2KB
Regulatory Filings
2019-05-30 English
Results of Annual General Meeting 2 pages 192.1KB
Regulatory Filings
2019-05-30 English
Imagion Biosystems successfully completes toxicology study 1
Regulatory Filings
2019-05-22 English
Non-Deal Roadshow Presentation 16 pages 5.5MB
Regulatory Filings
2019-05-20 English
Imagion Biosystems receives R&D Advanced Overseas Finding 1
Regulatory Filings
2019-05-12 English
Notice of Annual General Meeting/Proxy Form 17 pages 634.8KB
Regulatory Filings
2019-05-01 English
Annual Report to shareholders 59 pages 1.4MB
Regulatory Filings
2019-04-29 English
Appendix 4G and Corporate Governance Statement 29 pages 638.5KB
Regulatory Filings
2019-04-29 English
Appendix 4C - quarterly 5 pages 218.5KB
Regulatory Filings
2019-04-25 English
IBX receives order related to cancer treatment 1 pa
Regulatory Filings
2019-04-10 English
FY2018 Financial Report 49 pages 597.4KB
Regulatory Filings
2019-03-28 English
IBX receives US patent related to treatment of disease 1
Regulatory Filings
2019-03-11 English
FY2018 Appendix 4E and Preliminary Report 16 pages 378.4KB
Regulatory Filings
2019-02-27 English
Imagion Biosystems initiates toxicology study 1 pag
Regulatory Filings
2019-02-19 English
Appendix 4C - quarterly 7 pages 316.3KB
Regulatory Filings
2019-01-30 English
Becoming a substantial holder 2 pages 123.3KB
Regulatory Filings
2019-01-29 English
Becoming a substantial holder 2 pages 130.0KB
Regulatory Filings
2019-01-29 English